Intensity Therapeutics, Inc. Common stock (INTS) News
Latest headlines that mention INTS, newest first · each headline opens the original publisher
- Last price
- $3.15
- Day change
- +5.00%
- Next earnings
- —
INTS headlines
latest coverageNot much coverage yet. INTS has appeared in only a few headlines lately; new stories show up here as publishers cover it.
Enrollment restarts as cash burn rises and partnership talks advance.
CEO discusses resuming trials and $30M capital needs for Phase 3 sarcoma study.
INTS news alerts
Get an alert by email or push when a new headline mentions INTS.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.